MedPage Today brought together three expert leaders in the field: Moderator Peter K. Kaiser, MD, of the Cleveland Clinic, is joined by Yasha S. Modi, MD, of New York University Langone Health in New ...

Find out how higher dose aflibercept may reduce injection burden while preserving vision in retinal vasculopathy.

Although treatment with anti-VEGF agents has improved the outcomes for patients with AMD, it has also placed a large burden on ophthalmic providers. The current study found that the incidence of nAMD ...

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

In the retina, age-related macular degeneration (AMD) affects the complex of photoreceptors, retinal pigment epithelium (RPE), Bruch’s membrane (BM) and the choriocapillaris, the innermost layer of ...

Patients with age-related macular degeneration (AMD) initially may present with distortions in fine visual perception, and disease may be asymptomatic. As the disease develops over time, vision ...

South Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes ...

About The Study: In this cohort study, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) among patients with diabetes was associated with a 2-fold higher risk of incident neovascular ...

Kalaris Therapeutics ( ($KLRS) ) just unveiled an announcement. Kalaris Therapeutics announced on December 17, 2025, positive initial data from ...